ResearcherFirst Affiliated Hospital of Kunming Medical UniversityActive in the last 2 years
Xu Wei Luo
Matched on ORCID iD 0009-0003-8327-9667; OpenAlex author ID A5113623083. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2024: 2 papers · 2025: 1 paper
Papers 3
- Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume… Co-author DOI 10.1016/j.tranon.2024.102252↗
- Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/STAT3 pathway. Co-author DOI 10.1007/s11033-023-09105-w↗
- Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. Co-author DOI 10.1016/j.tranon.2023.101803↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xudong Zhao · 2 shared papers, 2024–2025 · strength 0.47
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Yuncang Yuan · 2 shared papers, 2024–2025 · strength 0.47
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Yongjie Zhu · 2 shared papers, 2024–2025 · strength 0.47
- Paper Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinica… DOI 10.1016/j.tranon.2024.102252↗
- Paper Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. DOI 10.1016/j.tranon.2023.101803↗
- Guoqing Bao · 1 shared paper, 2024 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.